These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1783798)

  • 1. Negativity rate in multibacillary leprosy after MDT.
    Naik S; Shere SS; Ganapati R
    Indian J Lepr; 1991; 63(2):243-4. PubMed ID: 1783798
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of relapse within 4 years among 34 multibacillary patients with high BIs treated for 2 years with MDT.
    Jesudasan K; Vijayakumaran P; Manimozhi N; Jeyarajan T; Rao PS
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):133-5. PubMed ID: 8690971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug therapy in multibacillary leprosy; experience in an urban leprosy center.
    Ramesh V; Misra RS; Saxena U
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):13-7. PubMed ID: 1602189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-duration therapy (FDT) in multibacillary leprosy; efficacy and complications.
    Vijayakumaran P; Jesudasan K; Manimozhi N
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):123-7. PubMed ID: 8690969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial clearance with WHO--recommended multidrug regimen for multibacillary leprosy.
    Kishore BN; Shetty JN
    Indian J Lepr; 1995; 67(3):301-8. PubMed ID: 8576609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY; Hu LF; Wu PW; Luo JS; Liu XM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.
    Balagon MF; Cellona RV; Cruz Ed; Burgos JA; Abalos RM; Walsh GP; Saunderson PR; Walsh DS
    Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of MDT strategies through epidemiometric modeling.
    Lechat MF; Declercq EE; Misson CB; Vellut CM
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):296-301. PubMed ID: 2115904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of MDT in multibacillary leprosy.
    Jesudasan K; Vijayakumaran P; Manimozhi N; Rao PS; Samuel P
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):128-32. PubMed ID: 8690970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of relapse and reactions in MB leprosy patients after 24 and 12 months of MDT in Maharashtra.
    Deshpande J; Chougule SG; Thakar UH; Revankar CR
    Indian J Lepr; 2004; 76(3):229-30. PubMed ID: 15835608
    [No Abstract]   [Full Text] [Related]  

  • 14. Six months MDT for paucibacillary leprosy: nerve damage and relapse.
    Wheate HW
    Lepr Rev; 1986 Jun; 57(2):179. PubMed ID: 3747708
    [No Abstract]   [Full Text] [Related]  

  • 15. Polytherapy in multibacillary leprosy patients in Nepal.
    Samuel NM; Samual S; Fairbairn T; Adiga RB
    Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of relapse in leprosy after fixed-duration multidrug therapy.
    Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disabilities in multibacillary leprosy patients: before, during and after multidrug therapy.
    Sharma P; Kar HK; Beena KR; Kaur H; Narayan R
    Indian J Lepr; 1996; 68(2):127-36. PubMed ID: 8835580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
    Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
    Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.